LivaNova Advanced Circulatory Support exists to deliver life support simplified to more patients in more places. We strive to develop innovative, easy to use cardiac and cardiopulmonary solutions for patients who require a high level of support – including ECMO for COVID-19 patients. In addition, LivaNova recently acquired ALung Technologies, known for its innovative Hemolung, the first and only fully integrated, FDA cleared system for extracorporeal CO2 removal.
We break down the barriers to advanced care for healthcare professionals and their critically ill patients through the simplicity and versatility of our product platforms.
Built on 20 years of experience in temporary life support products, LivaNova ACS offers leading edge technology for hospitals of all sizes and experience levels, including our next-generation LifeSPARC® pump and controller, ProtekDuo® dual lumen cannula and TandemHeart® transseptal cannula.